Page 5 - Dermavant Sciences News Today

- Two posters will highlight clinical data for VTAMA cream on treat-to-target outcomes and quality of life measures - Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing

Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing ...

Newly launched U.S. drugs head toward record-high prices in 2022

By Deena Beasley (Reuters) - Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their ...

Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill

The pharmaceutical industry is coming under fire again for their pricing as they are launching new medicines at record prices this year.

WEDNESDAY, July 13, 2022 (HealthDay News) -- Four in 10 plaque psoriasis patients achieve complete disease clearance with tapinarof cream, 1 percent, according to a study published online June 26 in the Journal of the American Academy of Dermatology. Bruce Strober, M.D., Ph.D., from Yale University in New Haven, Connecticut, and colleagues assessed the long-term

Plaque Psoriasis market size is anticipated to increase in the coming years due to several factors such as an increased patient pool, alongside potential emerging Plaque Psoriasis treatment

/PRNewswire/ -- DelveInsights Plaque Psoriasis Market Insights report proffers a detailed comprehension of the Plaque Psoriasis market size by treatment,...

Press release content from Business Wire. The AP news staff was not involved in its creation.